Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4868798 | 0.99 | HSD17B10 (0.30) | HSD17B10TRPV1MEN1MAPTKMT2A | |
| SCHEMBL5920141 | 0.84 | PLK1 (0.31) | — | |
| SCHEMBL4866830 | 0.83 | PLK1 (0.31) | — | |
| SCHEMBL5676608 | 0.82 | TYR (0.38) | HSD17B10MEN1MAPTKMT2A | |
| SCHEMBL4860792 | 0.82 | TYR (0.38) | HSD17B10MEN1MAPTKMT2A | |
| SCHEMBL5678097 | 0.80 | CNR1 (0.38) | TRPV1 | |
| SCHEMBL5919947 | 0.77 | FFAR1 (0.36) | MEN1MAPTKMT2A | |
| SCHEMBL5920806 | 0.76 | FFAR1 (0.35) | MEN1MAPTKMT2A | |
| SCHEMBL5920956 | 0.76 | FFAR1 (0.35) | MEN1MAPTKMT2A | |
| SCHEMBL5920811 | 0.76 | FFAR1 (0.35) | MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | ZHAO BAIYI | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | COMT, CD69, SPR | HSD17B10 3502/4885TRPV1 1255/4885MEN1 3718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.